Three of the largest prescription drug distributors in the United States have agreed to pay a total of $1.179 billion to resolve allegations brought by New York state that the companies helped fuel the opioid crisis by failing to comply with their duties to detect and report the diversion of opioid drugs. The distributors’ compliance failures were due to “poorly designed, poorly re... Read More